SLD

SALUDA MED CDI FORUS [SLD]
Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesota.
Healthcare · ASX Small Cap
$0.4100 +1.2%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-16
Get alerts when SLD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track SLD — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Lagging the Small Ords index — relative strength of 0.65, underperforming its peers
  • Adequate cash runway (4 quarters)
  • Strong revenue growth (+38%)
  • Near 52-week low (3% of range)
  • CANSLIM I: Institutional ownership (31%)
  • Revenue growth 43% YoY (from results)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Deeply negative margins (-166%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 49% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.41%/day)

Recent Catalysts

NONE CEO Transition
NONE S&P DJI Announces September 2026 Quarterly Rebalance
NONE Change in substantial holding

Recent ASX Announcements

2026-09-07 CEO Transition PRICE SENSITIVE
2026-09-04 S&P DJI Announces September 2026 Quarterly Rebalance PRICE SENSITIVE
2026-08-28 Change in substantial holding
2026-08-27 FY26 Results Presentation PRICE SENSITIVE
2026-08-27 FY26 Full Year Results PRICE SENSITIVE

Key Metrics

N/A
Market Cap
502K
Avg Volume
1.3x
Vol Ratio
$0.36 — $1.90
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
N/A
ROE
-165.9%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual Earningsinsufficient_dataCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & Demandinsufficient_dataFloat: 0%
LLeader vs LaggardpassRS: 2
IInstitutional SponsorshippassInst: 31%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:SLD vs NUZSLD vs IPDSLD vs HIQ
Share this analysis

Track SLD and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required